Product Information

ABILIFY ASIMTUFII 720 MG/2.4 ML is a brand product labeled by Otsuka America Pharmaceutical Inc., priced at $1786.4257 per ML under NDC 59148010280. Its NADAC has been published 136 times since Apr 17, 2024.

FDA first approved this application on Apr 27, 2023.

The High Outlier badge above means this manufacturer's average price in the Aripiprazole market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ABILIFY ASIMTUFII 720 MG/2.4 ML

Aripiprazole
$1786.4257per ML
High Outlier

Strength

720 mg/2.4mL

NDC

59148010280

Classification

Brand

Dosage Form

INJECTION, SUSPENSION, EXTENDED RELEASE

Route

INTRAMUSCULAR

Effective Date

11/18/2026

Active Ingredients

ARIPIPRAZOLE

Approval Type

New Drug (NDA)

FDA Application

NDA217006

FDA Approved

4/27/2023

On Market Since

4/27/2023

Pharmacological Classes

Price Statistics

The NADAC for ABILIFY ASIMTUFII 720 MG/2.4 ML has been published 136 times since Apr 17, 2024, and over the history we have for it it has risen 6.0%. The table below summarizes its recorded NADAC range and movement.

Current price$1786.4257 per ML
All-time high$1786.4257 (Nov 18, 2026)
All-time low$1681.2338 (May 22, 2024)
52-week high$1786.4257
52-week low$1723.9799
Median price$1735.8802
Average price$1734.7880
Largest weekly change+3.0% (Jan 8, 2025)
Weeks tracked136
Tracking sinceApr 17, 2024

Price History

1W

0.0%

1M

0.0%

3M

+0.0%

6M

+0.8%

1Y

+3.4%

3Y

N/A

5Y

N/A

All

+6.0%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Aripiprazole market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ABILIFY ASIMTUFII 720 MG/2.4 ML?

The current National Average Drug Acquisition Cost (NADAC) for ABILIFY ASIMTUFII 720 MG/2.4 ML, manufactured by Otsuka America Pharmaceutical Inc., is $1786.4257 per ML (NDC 59148010280), effective Nov 18, 2026.

How has the price of ABILIFY ASIMTUFII 720 MG/2.4 ML changed over time?

Over the history we have for it, the NADAC for ABILIFY ASIMTUFII 720 MG/2.4 ML has risen 6.0%. It has been tracked across 136 weekly CMS publications since Apr 17, 2024.

What are the highest and lowest recorded NADAC prices for ABILIFY ASIMTUFII 720 MG/2.4 ML?

Since Apr 17, 2024, the NADAC for ABILIFY ASIMTUFII 720 MG/2.4 ML has ranged from a low of $1681.2338 (May 22, 2024) to a high of $1786.4257 (Nov 18, 2026), with a median of $1735.8802 per ML.

Are there cheaper alternatives to ABILIFY ASIMTUFII 720 MG/2.4 ML?

No other NADAC-published product currently shares the active ingredient and strength of ABILIFY ASIMTUFII 720 MG/2.4 ML in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ABILIFY ASIMTUFII 720 MG/2.4 ML?

ABILIFY ASIMTUFII 720 MG/2.4 ML (NDC 59148010280) is labeled by Otsuka America Pharmaceutical Inc., and CMS classifies it as a brand product.